One Global Service Provider Limited
BSE: ONEGLOBAL · Healthcare Service Provider
Snapshot
Unlock One Global Service Provider Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
One Global Service Provider Ltd. is an Indian company engaged in the provision of healthcare services. Established in 1992, the firm is headquartered in Mumbai.
Business Model
The company operates within the healthcare services sector, generating revenue through the delivery of medical and health-related support services.
Growth Outlook
Future growth is expected to align with the broader expansion of the Indian healthcare services market and increasing demand for professional medical support.
Key Risks
- Regulatory Compliance. The company faces risks associated with evolving healthcare regulations and licensing requirements in India.
- Operational Competition. Intense competition within the healthcare services sector may impact market share and pricing power.
- Human Capital Dependency. The quality and availability of skilled medical and administrative personnel are critical to maintaining service standards.
Start your research today
Unlock AI insights, financials, peers and live data on One Global Service Provider Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹513 Cr
TTM · standalone
NET PROFIT
₹74 Cr
TTM · standalone
EPS
₹37.84
TTM · standalone
RETURN ON EQUITY
69.4%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
92.5%
TTM · standalone
P/E
13.9×
Q1 FY27 · standalone
EV/EBITDA
10.5x
Q1 FY27 · standalone
EBITDA MARGIN
19.4%
TTM · standalone
NET PROFIT MARGIN
13.9%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Healthcare Service Provider
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
One Global Service Provider LimitedONEGLOBAL | ₹1,062 Cr | 13.9× | 10.52 | 161.6% | 19.4% | 69.4% | 92.5% | +93.2% |
Nephrocare Health ServicesNEPHROPLUS | ₹7,444 Cr | — | — | — | 23.0% | — | — | — |
Suraksha Diagnostic Ltd.SURAKSHA | ₹1,851 Cr | 50.0× | 17.47 | 22.5% | 32.7% | 15.8% | 18.6% | +17.7% |
Krsnaa Diagnostics Ltd.KRSNAA | ₹1,817 Cr | 18.5× | 8.75 | 10.2% | 32.5% | 10.5% | 13.3% | -28.2% |
3B BlackBio Dx Ltd3BBLACKBIO | ₹1,229 Cr | 25.1× | 14.76 | 54.3% | 52.8% | 19.0% | 24.1% | +18.1% |
Gaudium IVF and Women Health LimitedGAUDIUMIVF | ₹857 Cr | — | — | — | 36.0% | — | — | — |
As of Q1 FY27
Financials
One Global Service Provider Limited
BSE: ONEGLOBAL · Healthcare Service Provider
Snapshot
Unlock One Global Service Provider Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
One Global Service Provider Ltd. is an Indian company engaged in the provision of healthcare services. Established in 1992, the firm is headquartered in Mumbai.
Business Model
The company operates within the healthcare services sector, generating revenue through the delivery of medical and health-related support services.
Growth Outlook
Future growth is expected to align with the broader expansion of the Indian healthcare services market and increasing demand for professional medical support.
Key Risks
- Regulatory Compliance. The company faces risks associated with evolving healthcare regulations and licensing requirements in India.
- Operational Competition. Intense competition within the healthcare services sector may impact market share and pricing power.
- Human Capital Dependency. The quality and availability of skilled medical and administrative personnel are critical to maintaining service standards.
Start your research today
Unlock AI insights, financials, peers and live data on One Global Service Provider Limited and 5,000+ companies — free.
Key Metrics
REVENUE
₹513 Cr
TTM · standalone
NET PROFIT
₹74 Cr
TTM · standalone
EPS
₹37.84
TTM · standalone
RETURN ON EQUITY
69.4%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
92.5%
TTM · standalone
P/E
13.9x
Q1 FY27 · standalone
EV/EBITDA
10.5x
Q1 FY27 · standalone
EBITDA MARGIN
19.4%
TTM · standalone
NET PROFIT MARGIN
13.9%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Healthcare Service Provider
As of Q1 FY27